FDA Adverse Event Injury Summary report: N

ACCU-CHEK FASTCLIX

MDR report key: 19722351 · Received July 10, 2024

Report

Report Number
MW5157211
Event Type
Injury
Date Received
July 10, 2024
Date of Event
January 13, 2024
Report Date
July 8, 2024
Manufacturer
ROCHE DIABETES CARE, INC.
Product Code
QRL
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
TN, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

FOLLOWING MY DOCTOR'S APPOINTMENT, THE DOCTOR INSTRUCTED ME TO CHECK MY SUGAR AND LOG MY RESULTS. I FILLED MY ORDER WITH (B)(6) ON (B)(6) 2024 AND STARTED USING THE PRODUCT ON (B)(6) 2024. AFTER I PRICKED MY FINGER, I NOTICED MY FINGER BEGAN TO TURN RED AND SWOLLEN PAIN AT THE INJECTION SITE, FOLLOWED BY A FEVER. I COULDN'T FIGURE OUT THE CAUSE OF MY PROBLEM, IT JUST HAPPENED EVERY TIME I CHECKED MY BLOOD SUGAR. BECAUSE I WAS NEW TO CHECKING MY SUGAR, I THOUGHT THESE WERE THE NORMAL SIDE EFFECTS OF THE LANCET. THERE WERE DAYS WHEN I FELT ILL WITH MILD SYMPTOMS RANGING FROM FEVER TO SEVERE HEADACHE AND VOMITING INCLUDING MY FINGER TURNING BLACK. AFTER I USED TWO FILLED BOXES OF FASTCLIX, I DECIDED TO DISCONTINUE THE PRODUCT ENTIRELY AND JUST STARTED INSULIN WITH NO RECORD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2386366 ACCU-CHEK FASTCLIX MULTIPLE USE BLOOD LANCET FOR SINGLE PATIENT USE ONLY QRL ROCHE DIABETES CARE, INC.

Patients

Seq Age Sex Outcome Treatment
1 60 YR Male Other ASPIRIN.| DICLOFFENAC SODIUM 75MG.| GABAPENTIN 300MG.| HYDROCODONE.| LOVASTATIN.| METOPROLOL TARTRATE.